These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13425233)

  • 21. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 22. [Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].
    NEUHOLD K; TAESCHLER M; CERLETTI A
    Helv Physiol Pharmacol Acta; 1957; 15(1):1-7. PubMed ID: 13428196
    [No Abstract]   [Full Text] [Related]  

  • 23. Incorporation of a lysergic acid diethylamide intermediate into antibody protein in vitro.
    Voss EW; Metzel P; Winkelhake JL
    Mol Pharmacol; 1973 May; 9(3):421-5. PubMed ID: 4736291
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentiation of substance P by lysergic acid diethvlamide in vivo.
    KRIVOY WA
    Br J Pharmacol Chemother; 1961 Jun; 16(3):253-6. PubMed ID: 13754427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis of ergot alkaloids in Claviceps paspali. 3. Incorporation of 6-methyl-delta-8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H.
    Agurell S
    Acta Pharm Suec; 1966 Apr; 3(2):65-70. PubMed ID: 5946518
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydrolysis of lysergamide to lysergic acid by Rhodococcus equi A4.
    Martínková L; Kren V; Cvak L; Ovesná M; Prepechalová I
    J Biotechnol; 2001 Nov; 84(1):63-6. PubMed ID: 11035188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay of lysergic acid diethylamide and its passage from blood into the perfused cerebral ventricles.
    DRASKOCI M
    Br J Pharmacol Chemother; 1960 Mar; 15(1):29-34. PubMed ID: 13818017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
    Lovell RA; Freedman DX
    Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
    [No Abstract]   [Full Text] [Related]  

  • 29. Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.
    Green JP; Johnson CL; Weinstein H; Maayani S
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5697-701. PubMed ID: 23536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRELIMINARY STUDIES OF THE DISTRIBUTION AND FATE OF BR82- LABELLED 2-BROM-D-LYSERGIC ACID DIETHYLAMIDE (BOL) IN THE HUMAN BODY.
    KALBHEN DA; SARGENT TW
    Med Exp Int J Exp Med; 1963; 8():200-8. PubMed ID: 14044341
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 32. PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
    AGHAJANIAN GK; BING OH
    Clin Pharmacol Ther; 1964; 5():611-4. PubMed ID: 14209776
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fate of lysergic acid di[ 14C]ethlamide ([14-C-A1LSD) in the rat.
    Siddik ZH; Barnes RD; Dring LG; Smith RL; Williams RT
    Biochem Soc Trans; 1975; 3(2):290-2. PubMed ID: 1132562
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of D-lysergic acid diethylamide on cerebral circulation and overall metabolism.
    SOKOLOFF L; PERLIN S; KORNETSKY C; KETY SS
    Ann N Y Acad Sci; 1957 Mar; 66(3):468-77. PubMed ID: 13425236
    [No Abstract]   [Full Text] [Related]  

  • 36. The biochemistry of hallucinogens.
    LAJTHA A
    Prog Neurobiol (1956); 1958; Vol. 3():126-51. PubMed ID: 13579017
    [No Abstract]   [Full Text] [Related]  

  • 37. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 38. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Distribution of lysergic acid diethylamide in the organism].
    LANZ U; CERLETTI A; ROTHLIN E
    Helv Physiol Pharmacol Acta; 1955; 13(3):207-16. PubMed ID: 13306100
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.
    Ebersole BJ; Weinstein H; Maayani S
    J Pharmacol Exp Ther; 1984 Jun; 229(3):865-71. PubMed ID: 6726661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.